UnitedHealthcare pushing congress to open up federal workers' health program

At a congressional hearing yesterday, UnitedHealthCare executives said that Blue Cross Blue Shield dominates the FEHB market too much.

The Washington Post: Insurance Providers Debate Whether Federal Workers Should Have More Choices
Two leading health-insurance providers squared off during congressional testimony Thursday, debating whether the government should allow more plans to participate in the $47 billion health-benefits program for federal employees. At a hearing before the House subcommittee that oversees the federal workforce, United Healthcare urged lawmakers to allow regional and state preferred-provider organizations (PPOs) to join the health-benefit program, which covers about 8 million workers (Hicks, 4/11).

Kaiser Health News: Insurers Battle Over Federal Employees' Health Coverage
Tom Choate, chief growth officer for UnitedHealthcare, said the Blues' "monopoly" of the program is stifling competition and innovation of insurance products. "Much has changed since 1959. We've moved from typewriters to laptops; from rotary dial phones to smart phones; from 45s to iTunes," Choate said at the hearing. "It's time to update that 1959 law, so federal employees and the federal government can also benefit from innovation and competition in the health care marketplace" (Galewitz, updated 4/11). 


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
FDA strengthens AI regulation to ensure patient safety and innovation in healthcare